combining glp-1 receptor agonist with dpp-4 inhibitor not recommended guideline Clinical Focus on Agonists in Type 2 Diabetes Mellitus Combination therapy with once-weekly glucagon

this condition restores TGF via appropriate modulation of arteriolar tone (e.g., afferent vasoconstriction), which in turn reduces renal plasma flow and hyperfiltration

Sapir T., Shternhall K., MeivarLevy I., et al., CellReplacement Therapy for Diabetes: Generating Functional InsulinProducing Tissue From Adult Human Liver Cells, Proceedings of the National Academy of Sciences of the United States of America 102, no

Glucagon replacement via micro-osmotic pump corrects hypoglycemia and alpha-cell hyperplasia in prohormone convertase 2 knockout mice

Fura A., Khanna A., Vyas V., et al., Pharmacokinetics of the Dipeptidyl Peptidase 4 Inhibitor Saxagliptin in Rats, Dogs, and Monkeys and Clinical Projections, Drug Metabolism and Disposition 37, no

Eli Lilly has seven additional Phase 3 TRIUMPH trials expected to complete during the course of the coming months and into the following year